Fabian Priem

531 total citations
7 papers, 436 citations indexed

About

Fabian Priem is a scholar working on Molecular Biology, Rheumatology and Molecular Medicine. According to data from OpenAlex, Fabian Priem has authored 7 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Rheumatology and 3 papers in Molecular Medicine. Recurrent topics in Fabian Priem's work include Curcumin's Biomedical Applications (3 papers), Osteoarthritis Treatment and Mechanisms (3 papers) and Pharmacological Effects of Medicinal Plants (2 papers). Fabian Priem is often cited by papers focused on Curcumin's Biomedical Applications (3 papers), Osteoarthritis Treatment and Mechanisms (3 papers) and Pharmacological Effects of Medicinal Plants (2 papers). Fabian Priem collaborates with scholars based in Belgium, France and United States. Fabian Priem's co-authors include Yves Henrotin, Ali Mobasheri, Christelle Sanchez, Cécile Lambert, M. Mathy‐Hartert, Danièle Lacasa, Mayoura Kéophiphath, Ingrid Jacquemond‐Collet, Karine Clément and Julie Rodriguez and has published in prestigious journals such as Journal of Nutrition, Medicine & Science in Sports & Exercise and Osteoarthritis and Cartilage.

In The Last Decade

Fabian Priem

7 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabian Priem Belgium 7 184 160 155 133 69 7 436
Silvia Errichi Italy 8 77 0.4× 67 0.4× 55 0.4× 44 0.3× 11 0.2× 16 280
Y Fujiyama Japan 5 119 0.6× 103 0.6× 212 1.4× 10 0.1× 32 0.5× 6 536
Ledyane Taynara Marton Brazil 6 96 0.5× 35 0.2× 111 0.7× 18 0.1× 20 0.3× 8 378
Krishnaraju Venkata Alluri India 8 128 0.7× 184 1.1× 18 0.1× 69 0.5× 41 0.6× 20 303
Shizuka Miyashita Japan 12 139 0.8× 32 0.2× 86 0.6× 14 0.1× 18 0.3× 17 515
Vigneshwaran Pitchaimani Japan 14 162 0.9× 36 0.2× 40 0.3× 16 0.1× 25 0.4× 23 551
Madhu G. Soni United States 11 98 0.5× 52 0.3× 39 0.3× 10 0.1× 66 1.0× 15 334
Mahmood Ahmad Khan India 8 129 0.7× 41 0.3× 12 0.1× 56 0.4× 41 0.6× 16 435
Ying Han China 9 117 0.6× 35 0.2× 17 0.1× 25 0.2× 20 0.3× 46 317
Titi Liu China 12 245 1.3× 117 0.7× 9 0.1× 34 0.3× 112 1.6× 17 443

Countries citing papers authored by Fabian Priem

Since Specialization
Citations

This map shows the geographic impact of Fabian Priem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabian Priem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabian Priem more than expected).

Fields of papers citing papers by Fabian Priem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabian Priem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabian Priem. The network helps show where Fabian Priem may publish in the future.

Co-authorship network of co-authors of Fabian Priem

This figure shows the co-authorship network connecting the top 25 collaborators of Fabian Priem. A scholar is included among the top collaborators of Fabian Priem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabian Priem. Fabian Priem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Rodriguez, Julie, Nicolas Pierre, Damien Naslain, et al.. (2017). Urolithin B, a newly identified regulator of skeletal muscle mass. Journal of Cachexia Sarcopenia and Muscle. 8(4). 583–597. 53 indexed citations
2.
Rodriguez, Julie, Rodrigo Fernández‐Verdejo, Nicolas Pierre, Fabian Priem, & Marc Francaux. (2015). Endurance Training Attenuates Catabolic Signals Induced by TNF-α in Muscle of Mice. Medicine & Science in Sports & Exercise. 48(2). 227–234. 10 indexed citations
3.
Henrotin, Yves, Myriam Gharbi, Fabian Priem, et al.. (2014). Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial. BMC Complementary and Alternative Medicine. 14(1). 159–159. 76 indexed citations
4.
Henrotin, Yves, Fabian Priem, & Ali Mobasheri. (2013). Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management. SpringerPlus. 2(1). 56–56. 116 indexed citations
5.
Kéophiphath, Mayoura, Fabian Priem, Ingrid Jacquemond‐Collet, Karine Clément, & Danièle Lacasa. (2009). 1,2-Vinyldithiin from Garlic Inhibits Differentiation and Inflammation of Human Preadipocytes. Journal of Nutrition. 139(11). 2055–2060. 63 indexed citations
6.
Mathy‐Hartert, M., et al.. (2009). Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflammation Research. 58(12). 899–908. 110 indexed citations
7.
Sanchez, Christelle, et al.. (2007). 196 CURCUMIN INHIBITS INTERLEUKIN-6, -8, NITRIC OXIDE AND PROSTAGLANDIN E2 SYNTHESIS BY BOVINE CHONDROCYTES. Osteoarthritis and Cartilage. 15. C115–C115. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026